Approved Cellular and Gene Therapy Products
Below is a list of licensed products from the Office of Tissues and Advanced Therapies (OTAT).
Approved Products
- ABECMA (idecabtagene vicleucel)
Celgene Corporation, a Bristol-Myers Squibb Company - ALLOCORD (HPC, Cord Blood)
SSM Cardinal Glennon Children's Medical Center - BREYANZI
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company - CLEVECORD (HPC Cord Blood)
Cleveland Cord Blood Center - Ducord, HPC Cord Blood
Duke University School of Medicine - GINTUIT (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen)
Organogenesis Incorporated - HEMACORD (HPC, cord blood)
New York Blood Center - HPC, Cord Blood
Clinimmune Labs, University of Colorado Cord Blood Bank - HPC, Cord Blood - MD Anderson Cord Blood Bank
MD Anderson Cord Blood Bank - HPC, Cord Blood - LifeSouth
LifeSouth Community Blood Centers, Inc. - HPC, Cord Blood - Bloodworks
Bloodworks - IMLYGIC (talimogene laherparepvec)
BioVex, Inc., a subsidiary of Amgen Inc. - KYMRIAH (tisagenlecleucel)
Novartis Pharmaceuticals Corporation - LAVIV (Azficel-T)
Fibrocell Technologies - LUXTURNA
Spark Therapeutics, Inc. - MACI (Autologous Cultured Chondrocytes on a Porcine Collagen Membrane)
Vericel Corp. - PROVENGE (sipuleucel-T)
Dendreon Corp. - RETHYMIC
Enzyvant Therapeutics GmbH - STRATAGRAFT
Stratatech Corporation - TECARTUS (brexucabtagene autoleucel)
Kite Pharma, Inc. - YESCARTA (axicabtagene ciloleucel)
Kite Pharma, Incorporated - ZOLGENSMA (onasemnogene abeparvovec-xioi)
Novartis Gene Therapies, Inc.